Clozapine is an effective atypical antipsychotic in resistant
schizophrenia. It has fatal side effects such as
agranulocytosis, myocarditis and pulmonary embolism.
While pulmonary embolism due to clozapine treatment
was observed in the first 3 months, pulmonary embolism
developed in our case in the 19th year of clozapine
treatment. In this case, we presented the management of
clozapine-induced pulmonary embolism and its effect on
mental state.
Klozapin dirençli şizofrenide etkili bir atipik
antipsikotiktir. Agranülositoz, myokardit ve pulmoner
emboli gibi ölümcül yan etkilere sahiptir. Klozapin
tedavisine bağlı pulmoner emboli ilk 3 ayda görülürken
olgumuzda klozapin tedavisinin 19. yılında pulmoner
emboli gelişmiştir. Bu olguda klozapin tedavisine bağlı
pulmoner embolinin yönetimini ve ruhsal durum üzerine
etkisini sunduk
Primary Language | Turkish |
---|---|
Subjects | Clinical Sciences |
Journal Section | Case Report |
Authors | |
Publication Date | December 30, 2021 |
Published in Issue | Year 2021 Volume: 1 Issue: 2 |